Close

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 12/2/2024

1. RDNT
2. 3998:HK
3. RCO:FP
4. REMYY
5. CLGT:IN
6. FSPKF
7. BGM
8. ASTERDM:IN
9. GEHC
10. TNB:MK


AbbVie (ABBV) Falls 13% After Results for Emraclidine in Schizophrenia Did Not Meet their Primary Endpoint

November 11, 2024 8:36 AM EST Send to a Friend
AbbVie (NYSE: ABBV) Falls 13% After Results for Emraclidine in Schizophrenia Did Not Meet their Primary EndpointAbbVie (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login


Forgot Your Password?